Position in AMGN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$1,122,209
+$911,451 QoQ
Shares Held
3,099
+417.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#1,626
of 3,140 holders
Holding Since
Dec 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealth Management Associates, Inc. holds $14,108,701 across 10 Drug Manufacturers - General names. AMGN ranks #6 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,266 | $3,369,166 | |
| 2 | LLY |
ELI LILLY & Co
|
2,744 | $3,291,236 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,581 | $2,002,158 | |
| 4 | ABBV |
AbbVie Inc.
|
6,759 | $1,700,834 | |
| 5 | PFE |
Pfizer Inc
|
63,133 | $1,520,242 | |
| 6 | AMGN |
Amgen Inc
This page
|
3,099 | $1,122,209 | |
| 7 | AZN |
Astrazeneca PLC
|
1,780 | $337,523 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,535 | $320,271 |
All Filings in AMGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,122,209 | 3,099 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $210,758 | 599 | Shares | Sole | 2026-05-13 | |
| 2025-06-30 | $236,770 | 848 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $263,882 | 847 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $220,762 | 847 | Shares | Sole | 2025-05-28 | |
| 2024-09-30 | $224,580 | 697 | Shares | Sole | 2025-05-28 | |
| 2024-06-30 | $217,777 | 697 | Shares | Sole | 2025-05-28 | |
| 2024-03-31 | $198,171 | 697 | Shares | Sole | 2025-05-28 | |
| 2023-12-31 | $200,749 | 697 | Shares | Sole | 2025-05-28 | |
| 2021-12-31 | $601,119 | 2,672 | Shares | Sole | 2025-05-28 | |
| No filing history on record for this holder in this stock. | ||||||